170 related articles for article (PubMed ID: 37456882)
1. Establishment of a prognostic risk prediction modelfor non-small cell lung cancer patients with brainmetastases: a retrospective study.
Hou F; Hou Y; Sun XD; Lv J; Jiang HM; Zhang M; Liu C; Deng ZY
PeerJ; 2023; 11():e15678. PubMed ID: 37456882
[TBL] [Abstract][Full Text] [Related]
2. Applicability of the lung-molGPA index in non-small cell lung cancer patients with different gene alterations and brain metastases.
Chen K; Yu X; Zhang F; Xu Y; Zhang P; Huang Z; Fan Y
Lung Cancer; 2018 Nov; 125():8-13. PubMed ID: 30429042
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Prognostic Indices in NSCLC Patients with Brain Metastases after Radiosurgery.
Gao HX; Huang SG; Du JF; Zhang XC; Jiang N; Kang WX; Mao J; Zhao Q
Int J Biol Sci; 2018; 14(14):2065-2072. PubMed ID: 30585269
[TBL] [Abstract][Full Text] [Related]
4. Validation of the new Graded Prognostic Assessment scale for brain metastases: a multicenter prospective study.
Villà S; Weber DC; Moretones C; Mañes A; Combescure C; Jové J; Puyalto P; Cuadras P; Bruna J; Verger E; Balañà C; Graus F
Radiat Oncol; 2011 Mar; 6():23. PubMed ID: 21366924
[TBL] [Abstract][Full Text] [Related]
5. Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA).
Sperduto PW; Yang TJ; Beal K; Pan H; Brown PD; Bangdiwala A; Shanley R; Yeh N; Gaspar LE; Braunstein S; Sneed P; Boyle J; Kirkpatrick JP; Mak KS; Shih HA; Engelman A; Roberge D; Arvold ND; Alexander B; Awad MM; Contessa J; Chiang V; Hardie J; Ma D; Lou E; Sperduto W; Mehta MP
JAMA Oncol; 2017 Jun; 3(6):827-831. PubMed ID: 27892978
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic factors for non-small cell lung cancer patients with central nervous system metastasis with positive driver genes].
Li R; Zhang SR; Liu XF; Zhang JW; Zhao JY; Bai P; Zhang XC
Zhonghua Yi Xue Za Zhi; 2023 Apr; 103(16):1202-1209. PubMed ID: 37087403
[No Abstract] [Full Text] [Related]
7. Applicability of the adjusted graded prognostic assessment for lung cancer with brain metastases using molecular markers (Lung-molGPA) in a Chinese cohort: A retrospective study of multiple institutions.
Zhang T; Zhang Y; Zhou L; Deng S; Huang M; Liu Y; Liu Y; Gong Y; Zhu J; Xue J; Bai Y; Ma H; Zhang Y; Yu M; Li Y; Wang Y; Zou B; Zhou X; Xiu W; Na F; Xu Y; Peng F; Wang J; Lu Y
Cancer Med; 2020 Dec; 9(23):8772-8781. PubMed ID: 33027555
[TBL] [Abstract][Full Text] [Related]
8. Enhancing brain metastasis prediction in non-small cell lung cancer: a deep learning-based segmentation and CT radiomics-based ensemble learning model.
Gong J; Wang T; Wang Z; Chu X; Hu T; Li M; Peng W; Feng F; Tong T; Gu Y
Cancer Imaging; 2024 Jan; 24(1):1. PubMed ID: 38167564
[TBL] [Abstract][Full Text] [Related]
9. A novel quantitative prognostic model for initially diagnosed non-small cell lung cancer with brain metastases.
Li X; Gu W; Liu Y; Wen X; Tian L; Yan S; Chen S
Cancer Cell Int; 2022 Aug; 22(1):251. PubMed ID: 35948974
[TBL] [Abstract][Full Text] [Related]
10. Brain metastases in Japanese NSCLC patients: prognostic assessment and the use of osimertinib and immune checkpoint inhibitors-retrospective study.
Higaki H; Nishioka K; Otsuka M; Nishikawa N; Shido M; Minatogawa H; Nishikawa Y; Takashina R; Hashimoto T; Katoh N; Taguchi H; Kinoshita R; Yasuda K; Mori T; Uchinami Y; Koizumi F; Fujita Y; Takahashi S; Hattori T; Nishiyama N; Aoyama H
Radiat Oncol; 2023 Feb; 18(1):25. PubMed ID: 36750899
[TBL] [Abstract][Full Text] [Related]
11. Validation of a novel prognostic index: BMS-Score for patients with brain metastases of small cell lung cancer.
Hou R; Li H; Cao J; Song X; Zhang X; Wang W
Ann Palliat Med; 2021 Jan; 10(1):29-36. PubMed ID: 33440957
[TBL] [Abstract][Full Text] [Related]
12. A novel LASSO-derived prognostic model predicting survival for non-small cell lung cancer patients with M1a diseases.
Chen H; Huang C; Ge H; Chen Q; Chen J; Li Y; Chen H; Luo S; Zhao L; Xu X
Cancer Med; 2022 Mar; 11(6):1561-1572. PubMed ID: 35128839
[TBL] [Abstract][Full Text] [Related]
13. Development and Validation of an Immune-Based Prognostic Risk Score for Patients With Resected Non-Small Cell Lung Cancer.
He L; Huang Y; Chen X; Huang X; Wang H; Zhang Y; Liang C; Li Z; Yan L; Liu Z
Front Immunol; 2022; 13():835630. PubMed ID: 35401554
[TBL] [Abstract][Full Text] [Related]
14. New prognostic system specific for epidermal growth factor receptor-mutated lung cancer brain metastasis.
Zhu LH; Fan XW; Sun L; Ni TT; Li YQ; Wu CY; Wu KL
Front Oncol; 2023; 13():1093084. PubMed ID: 37020869
[TBL] [Abstract][Full Text] [Related]
15. A molecular graded prognostic assessment (molGPA) model specific for estimating survival in lung cancer patients with leptomeningeal metastases.
Yin K; Li YS; Zheng MM; Jiang BY; Li WF; Yang JJ; Tu HY; Zhou Q; Zhong WZ; Yang XN; Chen HJ; Yan HH; Li LL; Wu YL; Zhang XC
Lung Cancer; 2019 May; 131():134-138. PubMed ID: 31027690
[TBL] [Abstract][Full Text] [Related]
16. Survival time following resection of intracranial metastases from NSCLC-development and validation of a novel nomogram.
Ji X; Zhuang Y; Yin X; Zhan Q; Zhou X; Liang X
BMC Cancer; 2017 Nov; 17(1):774. PubMed ID: 29157203
[TBL] [Abstract][Full Text] [Related]
17. Robustness of the neurological prognostic score in brain metastasis patients treated with Gamma Knife radiosurgery.
Serizawa T; Higuchi Y; Nagano O; Matsuda S; Aoyagi K; Ono J; Saeki N; Iwadate Y; Hirai T; Takemoto S; Shibamoto Y
J Neurosurg; 2017 Nov; 127(5):1000-1006. PubMed ID: 27911235
[TBL] [Abstract][Full Text] [Related]
18. Applicability of graded prognostic assessment of lung cancer using molecular markers to lung adenocarcinoma patients with brain metastases.
Li H; Lian J; Han S; Wang W; Jia H; Cao J; Zhang X; Song X; Jia S; Ren J; Yang W; Xi Y; Lan S
Oncotarget; 2017 Sep; 8(41):70727-70735. PubMed ID: 29050314
[TBL] [Abstract][Full Text] [Related]
19. Construction of a nomogram to predict the prognosis of non-small-cell lung cancer with brain metastases.
Huang Z; Hu C; Tong Y; Fan Z; Zhao C
Medicine (Baltimore); 2020 Jul; 99(31):e21339. PubMed ID: 32756121
[TBL] [Abstract][Full Text] [Related]
20. Targeted Therapies and Utility of the Lung-molGPA in Non-Small-Cell Lung Cancer Patients with Brain Metastases.
Cacho-Díaz B; Cuapantécatl LD; Garcilazo-Reyes YJ; Cabrera-Miranda L; Hernandez-Martinez JM; Arrieta O
Oncology; 2022; 100(10):542-554. PubMed ID: 35988535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
